Huerta: Booster dose, fundamental against 1:16 variants
(CNN) -
The U.S. Centers for Disease Control and Prevention (CDC) on Tuesday backed the Food and Drug Administration's (FDA) decision to shorten the time needed between complete an initial series of Pfizer / BioNTech covid-19 vaccines and a six-month to five-month booster dose.
The CDC also agreed with the FDA's call to authorize a third dose in the series of primary vaccines for some immunosuppressed children ages 5 to 11, in line with its recommendation for moderately or severely immunocompromised adults.
Moderna booster dose raises omicron antibody levels, company says
Fauci: When receiving booster doses, your protection goes up 1:00
In the same announcement, the FDA authorized expanding the eligibility of booster shots for teens ages 12 to 15.
CDC's Advisory Committee on Immunization Practices is scheduled to meet Wednesday to discuss this issue.
“As we have done during the pandemic, we will continue to update our recommendations to ensure the best possible protection for the American people.
"Following FDA clearances, today's recommendations ensure that people can get a boost of protection against (the variant) omicron and increased cases across the country, and ensure that the most vulnerable children can get a dose. additional to optimize protection against COVID-19, "CDC Director Dr. Rochelle Walensky said in a statement.
“If you or your kids are eligible for a third dose or a booster, go out and get one as soon as you can.
Additionally, the FDA took action this week to authorize boosters for children ages 12-15, and I look forward to the ACIP meeting on Wednesday to discuss this issue. ”
advertising